Cianopramine
Cianopramine (INN) (developmental code name Ro 11-2465), also known as 3-cyanoimipramine, is a tricyclic antidepressant related to imipramine that acts as a serotonin reuptake inhibitor[1] and weak serotonin receptor antagonist.[2][3] It was investigated for the treatment of depression but was never marketed.[3]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H23N3 |
Molar mass | 305.425 g·mol−1 |
3D model (JSmol) | |
SMILES
|
See also
References
- Kenny M, Lenehan TJ, Lambe R, Darragh A, Brick I, Omer LM (1983). "Effects of a single oral dose of 3-cyano-imipramine on serotonin uptake and content of platelets in healthy volunteers". Psychopharmacology. 79 (4): 304–7. doi:10.1007/bf00433406. PMID 6407042. S2CID 3112636.
- Pawłowski L, Kwiatek H, Górka Z (1981). "Is Ro 11-2465 (cyan-imipramine) an antagonist of postsynaptic serotonin receptors?". Journal of Neural Transmission. 52 (1–2): 61–72. doi:10.1007/BF01253098. PMID 7288439. S2CID 41042435.
- Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 270–. ISBN 978-1-4757-2085-3.
5-HT1AR agonists | |
---|---|
GABAAR PAMs |
|
Gabapentinoids (α2δ VDCC blockers) | |
Antidepressants |
|
Sympatholytics (Antiadrenergics) |
|
Others | |
|
Acetylcholine receptor modulators | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adrenergic receptor modulators | |||||
---|---|---|---|---|---|
α1 |
| ||||
α2 |
| ||||
β |
| ||||
|
Histamine receptor modulators | |||||
---|---|---|---|---|---|
H1 |
| ||||
H2 |
| ||||
H3 |
| ||||
H4 |
| ||||
|
DAT (DRIs) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NET (NRIs) |
| ||||||||||||||
SERT (SRIs) |
| ||||||||||||||
VMATs |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine releasing agents • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
Serotonin receptor modulators | |||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5-HT1 |
| ||||||||||||||||||||||||||||||||||||||
5-HT2 |
| ||||||||||||||||||||||||||||||||||||||
5-HT3–7 |
| ||||||||||||||||||||||||||||||||||||||
|
Classes |
|
---|---|
Antidepressants (TCAs and TeCAs) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Others |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.